Epidemiology of primary brain tumor;Épidémiologie des tumeurs cérébrales primitives

Revue Neurologique

Volumn 165, Issue 8-9, 2009, Pages 650-670

  Loiseau, H ^a   Huchet, A ^a   Rue M ^a   Cowppli Bony, A ^a   Baldi, I ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Brain tumor; Epidemiology; Incidence; Registry; Risk factor

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; DIURETIC AGENT; DNA; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PSEUDOEPHEDRINE; TETRAHYDROCANNABINOL; TOBACCO SMOKE; TRANQUILIZER;

ALLERGY; BIRTH WEIGHT; BRAIN TUMOR; DIAGNOSTIC IMAGING; DIETARY INTAKE; ELECTROMAGNETIC FIELD; EPENDYMOMA; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GLIOBLASTOMA; HORMONE SUBSTITUTION; HUMAN; INDUSTRIALIZATION; IONIZING RADIATION; MENINGIOMA; MOBILE PHONE; NEURINOMA; PESTICIDE SPRAYING; RACE DIFFERENCE; REGISTER; REVIEW; RISK FACTOR; SEX DIFFERENCE; ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASE; CHILD; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENETICS; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 69949091190     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.04.002     Document Type: Review

References (238)

1. Aldape K., Simmons M.L., Davis R.L., et al. Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 88 (2000) 2342-2349
2. Aldrich T.E., Andrews K.W., and Liboff AR. Brain cancer risk and electromagnetic fields (EMFs): assessing the geomagnetic component. Arch Environ Health 56 (2001) 314-319
3. Balasubramaniam A., Shannon P., Hodaie M., et al. Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro Oncol 9 (2007) 447-453
4. Baldwin R.T., and Preston-Martin S. Epidemiology of brain tumors in childhood--a review. Toxicol Appl Pharmacol 199 (2004) 118-131
5. Ballard T., Lagorio S., De Angelis G., and Verdecchia A. Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med 71 (2000) 216-224
6. Barnholtz-Sloan J.S., and Kruchko C. Meningiomas: causes and risk factors. Neurosurg Focus 23 (2007) E2
7. Bauchet L., Rigau V., Mathieu-Daude H., et al. French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 84 (2007) 189-199
8. Becker N., Liebermann D., Wesch H., and Van Kaick G. Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study. Eur J Cancer 44 (2008) 1259-1268
9. Benson V.S., Pirie K., Green J., Casabonne D., and Beral V. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99 (2008) 185-190
10. Berg G., Spallek J., Schuz J., et al. Occupational exposure to radio frequency/microwave radiation and the risk of brain tumors: Interphone Study Group, Germany. Am J Epidemiol 164 (2006) 538-548
11. Bethke L., Murray A., Webb E., et al. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 100 (2008) 270-276
12. Bethke L., Sullivan K., Webb E., et al. The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev 17 (2008) 987-989
13. Bethke L., Sullivan K., Webb E., et al. CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer Lett 273 (2009) 312-315
14. Blettner M., Schlehofer B., Samkange-Zeeb F., et al. Medical exposure to ionising radiation and the risk of brain tumours: Interphone study group. Germany. Eur J Cancer 43 (2007) 1990-1998
15. Bliss P., Kerr G.R., and Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990. Clin Oncol (R Coll Radiol) 6 (1994) 361-363
16. Blitshteyn S., Crook J.E., and Jaeckle K.A. Is there an association between meningioma and hormone replacement therapy?. J Clin Oncol 26 (2008) 279-282
17. Bondy M.L., Scheurer M.E., Malmer B., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113 Suppl. (2008) 1953-1968
18. Brenner A.V., Butler M.A., Wang S.S., et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 28 (2007) 2543-2547
19. Brenner A.V., Linet M.S., Fine H.A., et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 99 (2002) 252-259
20. Brenner A.V., Linet M.S., Shapiro W.R., et al. Season of birth and risk of brain tumors in adults. Neurology 63 (2004) 276-281
21. Brenner D.J., Doll R., Goodhead D.T., et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 100 (2003) 13761-13766
22. Brenner D.J., and Hall E.J. Computed tomography--an increasing source of radiation exposure. N Engl J Med 357 (2007) 2277-2284
23. Bromberg J.E., Siemers M.D., and Taphoorn M.J. Is a "vanishing tumor" always a lymphoma?. Neurology 59 (2002) 762-764
24. Brooks D.R., Mucci L.A., Hatch E.E., and Cnattingius S. Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1. 4 million Swedish births. Cancer Causes Control 15 (2004) 997-1005
25. Bunin G.R., Robison L.L., Biegel J.A., Pollack I.F., and Rorke-Adams L.B. Parental heat exposure and risk of childhood brain tumor: a Children's Oncology Group study. Am J Epidemiol 164 (2006) 222-231
26. Caggana M., Kilgallen J., Conroy J.M., et al. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10 (2001) 355-360
27. Cantor K.P., Lynch C.F., Hildesheim M.E., et al. Drinking water source and chlorination byproducts in Iowa. III. Risk of brain cancer. Am J Epidemiol 150 (1999) 552-560
28. Cantor K.P., Lynch C.F., and Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4 (1993) 505-511
29. Carroll R.S., Glowacka D., Dashner K., and Black P.M. Progesterone receptor expression in meningiomas. Cancer Res 53 (1993) 1312-1316
30. Castillo M.S., Davis F.G., Surawicz T., et al. Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems. Neuroepidemiology 23 (2004) 85-93
31. Chang J.S., Yeh R.F., Wiencke J.K., et al. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev 17 (2008) 1368-1373
32. Chen H., Ward M.H., Tucker K.L., et al. Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control 13 (2002) 647-655
33. Chen P., Aldape K., Wiencke J.K., et al. Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res 61 (2001) 3949-3954
34. Chen P., Wiencke J., Aldape K., et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 9 (2000) 843-847
35. Chen P., Wiencke J.K., Conway K., et al. Lack of association of rare alleles in the HRAS variable number of tandem repeats (VNTR) region with adult glioma. Neuro Oncol 2 (2000) 120-124
36. Christensen H.C., Kosteljanetz M., and Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 52 (2003) 1327-1333 1333-4 discussion
37. Cicuttini F.M., Hurley S.F., Forbes A., et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71 (1997) 203-207
38. Claus E.B., Black P.M., Bondy M.L., et al. Exogenous hormone use and meningioma risk: what do we tell our patients?. Cancer 110 (2007) 471-476
39. Claus E.B., Bondy M.L., Schildkraut J.M., et al. Epidemiology of intracranial meningioma. Neurosurgery 57 (2005) 1088-1095 1088-95 discussion
40. Costa B.M., Ferreira P., Costa S., et al. Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res 13 (2007) 2621-2626
41. Counsell C.E., Collie D.A., and Grant R. Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90. J Neurol Neurosurg Psychiatry 61 (1996) 143-150
42. Custer B., Longstreth Jr. W.T., Phillips L.E., Koepsell T.D., and Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6 (2006) 152
43. Davis F.G., Freels S., Grutsch J., Barlas S., and Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 88 (1998) 1-10
44. Davis F.G., Kupelian V., Freels S., McCarthy B., and Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3 (2001) 152-158
45. Davis F.G., Malmer B.S., Aldape K., et al. Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 17 (2008) 484-489
46. de Andrade M., Barnholtz J.S., Amos C.I., et al. Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 20 (2001) 258-270
47. Dearlove J.V., Fisher P.G., and Buffler P.A. Family history of cancer among children with brain tumors: a critical review. J Pediatr Hematol Oncol 30 (2008) 8-14
48. Deorah S., Lynch C.F., Sibenaller Z.A., and Ryken T.C. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20 (2006) E1
49. Dreifaldt A.C., Carlberg M., and Hardell L. Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998. Eur J Cancer 40 (2004) 1351-1360
50. Efird J.T., Friedman G.D., Sidney S., et al. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 68 (2004) 57-69
51. Elia-Pasquet S., Provost D., Jaffre A., et al. Incidence of central nervous system tumors in Gironde, France. Neuroepidemiology 23 (2004) 110-117
52. Elwood J.M. Epidemiological studies of radio frequency exposures and human cancer. Bioelectromagnetics Suppl 6 (2003) S63-73
53. Erfurth E.M., Bulow B., Mikoczy Z., and Hagmar L. Incidence of a second tumor in hypopituitary patients operated for pituitary tumors. J Clin Endocrinol Metab 86 (2001) 659-662
54. Erfurth E.M., Bulow B., Mikoczy Z., Svahn-Tapper G., and Hagmar L. Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour?. Clin Endocrinol (Oxf) 55 (2001) 613-616
55. Felini M.J., Olshan A.F., Schroeder J.C., et al. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20 (2009) 87-96
56. Filippini G., Maisonneuve P., McCredie M., et al. Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the SEARCH international case-control study. Surveillance of Environmental Aspects Related to Cancer in Humans. Int J Cancer 100 (2002) 206-213
57. Fleury A., Menegoz F., Grosclaude P., et al. Descriptive epidemiology of cerebral gliomas in France. Cancer 79 (1997) 1195-1202
58. Flint-Richter P., and Sadetzki S. Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study. Lancet Oncol 8 (2007) 403-410
59. Goshen Y., Stark B., Kornreich L., et al. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49 (2007) 294-297
60. Grossman S.A., Osman M., Hruban R., and Piantadosi S. Central nervous system cancers in first-degree relatives and spouses. Cancer Invest 17 (1999) 299-308
61. Guillamo J.S., Creange A., Kalifa C., et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126 (2003) 152-160
62. Gundestrup M., and Storm H.H. Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: a population-based cohort study. Lancet 354 (1999) 2029-2031
63. Gurney J.G., and Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13 (2001) 160-166
64. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N Engl J Med 347 (2002) 1593-1603
65. Halperin E.C., Miranda M.L., Watson D.M., George S.L., and Stanberry M. Medulloblastoma and birth date: evaluation of 3 U, S. datasets. Arch Environ Health 59 (2004) 26-30
66. Hardell L., Carlberg M., Soderqvist F., and Hansson Mild K. Meta-analysis of long-term mobile phone use and the association with brain tumours. Int J Oncol 32 (2008) 1097-1103
67. Hardell L, Hansson Mild K. (2006). Mobile phone use and risk of acoustic neuroma: results of the interphone case-control study in five North European countries. Br J Cancer 94: 1348-9; author reply 1352-3.
68. Hardell L., Mild K.H., and Carlberg M. Case-control study on the use of cellular and cordless phones and the risk for malignant brain tumours. Int J Radiat Biol 78 (2002) 931-936
69. Hardell L., Nasman A., Pahlson A., Hallquist A., and Hansson Mild K. Use of cellular telephones and the risk for brain tumours: A case-control study. Int J Oncol 15 (1999) 113-116
70. Harder T., Plagemann A., and Harder A. Birth weight and subsequent risk of childhood primary brain tumors: A meta-analysis. Am J Epidemiol 168 (2008) 366-373
71. Hatch E.E., Linet M.S., Zhang J., et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114 (2005) 797-805
72. Heineman E.F., Ward M.H., McComb R.D., Weisenburger D.D., and Zahm S.H. Hair dyes and risk of glioma among Nebraska women. Cancer Causes Control 16 (2005) 857-864
73. Helseth A. The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J Neurosurg 83 (1995) 999-1003
74. Hemminki K., and Li X. Familial risks in nervous system tumors. Cancer Epidemiol Biomarkers Prev 12 (2003) 1137-1142
75. Hemminki K., and Li X. Association of brain tumours with other neoplasms in families. Eur J Cancer 40 (2004) 253-259
76. Hepworth S.J., Schoemaker M.J., Muir K.R., et al. Mobile phone use and risk of glioma in adults: case-control study. BMJ 332 (2006) 883-887
77. Hess K.R., Broglio K.R., and Bondy M.L. Adult glioma incidence trends in the United States, 1977-2000. Cancer 101 (2004) 2293-2299
78. Heuch J.M., Heuch I., Akslen L.A., and Kvale G. Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. Int J Cancer 77 (1998) 498-503
79. Hill D.A., Inskip P.D., Shapiro W.R., et al. Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev 12 (2003) 1443-1448
80. Hill D.A., Linet M.S., Black P.M., et al. Meningioma and schwannoma risk in adults in relation to family history of cancer. Neuro Oncol 6 (2004) 274-280
81. Hjalmars U., Kulldorff M., Wahlqvist Y., and Lannering B. Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors. Cancer 85 (1999) 2077-2090
82. Hochberg F., Toniolo P., Cole P., and Salcman M. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 8 (1990) 55-60
83. Hoffman S., Propp J.M., and McCarthy B.J. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 8 (2006) 27-37
84. Hoffman S., Schellinger K.A., Propp J.M., et al. Seasonal variation in incidence of pediatric medulloblastoma in the United States, 1995-2001. Neuroepidemiology 29 (2007) 89-95
85. Holick C.N., Giovannucci E.L., Rosner B., Stampfer M.J., and Michaud D.S. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol 9 (2007) 326-334
86. Holly E.A., Bracci P.M., Hong M.K., Mueller B.A., and Preston-Martin S. West Coast study of childhood brain tumours and maternal use of hair-colouring products. Paediatr Perinat Epidemiol 16 (2002) 226-235
87. Houben M.P., Coebergh J.W., Birch J.M., et al. Space-time clustering patterns of gliomas in The Netherlands suggest an infectious aetiology. Eur J Cancer 41 (2005) 2917-2923
88. Houben M.P., Coebergh J.W., Birch J.M., et al. Space-time clustering of glioma cannot be attributed to specific histological subgroups. Eur J Epidemiol 21 (2006) 197-201
89. Houben M.P., Louwman W.J., Tijssen C.C., et al. Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann Oncol 15 (2004) 1256-1260
90. Huang K., Whelan E.A., Ruder A.M., et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 13 (2004) 1583-1588
91. Huncharek M., and Kupelnick B. A meta-analysis of maternal cured meat consumption during pregnancy and the risk of childhood brain tumors. Neuroepidemiology 23 (2004) 78-84
92. Huncharek M., Kupelnick B., and Klassen H. Maternal smoking during pregnancy and the risk of childhood brain tumors: a meta-analysis of 6566 subjects from twelve epidemiological studies. J Neurooncol 57 (2002) 51-57
93. Idbaih A., Boisselier B., Sanson M., et al. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas. Cancer Genet Cytogenet 176 (2007) 121-126
94. Inoue T., Akahira J., Suzuki T., et al. Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab 87 (2002) 5325-5331
95. Inskip P.D. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer. Cancer 98 (2003) 562-570
96. Inskip P.D., Tarone R.E., Brenner A.V., et al. Handedness and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 12 (2003) 223-225
97. Inskip P.D., Tarone R.E., Hatch E.E., et al. Sociodemographic indicators and risk of brain tumours. Int J Epidemiol 32 (2003) 225-233
98. Inskip P.D., Tarone R.E., Hatch E.E., et al. Cellular-telephone use and brain tumors. N Engl J Med 344 (2001) 79-86
99. Jhawar B.S., Fuchs C.S., Colditz G.A., and Stampfer M.J. Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99 (2003) 848-853
100. Johannesen T.B., Angell-Andersen E., Tretli S., Langmark F., and Lote K. Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology 23 (2004) 101-109
101. Johansen C., Boice Jr. J., McLaughlin J., and Olsen J. Cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst 93 (2001) 203-207
102. Jukich P.J., McCarthy B.J., Surawicz T.S., Freels S., and Davis F.G. Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro Oncol 3 (2001) 141-151
103. Kaatsch P., Rickert C.H., Kuhl J., Schuz J., and Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer 92 (2001) 3155-3164
104. Kaatsch P., Steliarova-Foucher E., Crocetti E., et al. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 1961-1971
105. Kadan-Lottick N.S., Skluzacek M.C., and Gurney J.G. Decreasing incidence rates of primary central nervous system lymphoma. Cancer 95 (2002) 193-202
106. Kan P., Simonsen S.E., Lyon J.L., and Kestle J.R. Cellular phone use and brain tumor: a meta-analysis. J Neurooncol 86 (2008) 71-78
107. Kaneko S., Nomura K., Yoshimura T., and Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973-1993. J Neurooncol 60 (2002) 61-69
108. Khuder S.A., Mutgi A.B., and Schaub E.A. Meta-analyses of brain cancer and farming. Am J Ind Med 34 (1998) 252-260
109. Kiuru A., Lindholm C., Heinavaara S., et al. XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol 88 (2008) 135-142
110. Klaeboe L., Blaasaas K.G., Haldorsen T., and Tynes T. Residential and occupational exposure to 50-Hz magnetic fields and brain tumours in Norway: a population-based study. Int J Cancer 115 (2005) 137-141
111. Klaeboe L., Lonn S., Scheie D., et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer 117 (2005) 996-1001
112. Korhonen K., Salminen T., Raitanen J., et al. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80 (2006) 1-7
113. Kundi M., Mild K., Hardell L., and Mattsson M.O. Mobile telephones and cancer--a review of epidemiological evidence. J Toxicol Environ Health B Crit Rev 7 (2004) 351-384
114. Kuratsu J., and Ushio Y. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan. J Neurosurg 84 (1996) 946-950
115. Lahkola A., Auvinen A., Raitanen J., et al. Mobile phone use and risk of glioma in 5 North European countries. Int J Cancer 120 (2007) 1769-1775
116. Lai R., Crevier L., and Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14 (2005) 1784-1790
117. Lambe M., Coogan P., and Baron J. Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72 (1997) 389-393
118. Larjavaara S., Mantyla R., Salminen T., et al. Incidence of gliomas by anatomic location. Neuro Oncol 9 (2007) 319-325
119. Lee E., Grutsch J., Persky V., et al. Association of meningioma with reproductive factors. Int J Cancer 119 (2006) 1152-1157
120. Legler J.M., Ries L.A., Smith M.A., et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91 (1999) 1382-1390
121. Liigant A., Asser T., Kulla A., and Kaasik A.E. Epidemiology of primary central nervous system tumors in Estonia. Neuroepidemiology 19 (2000) 300-311
122. Lim U., Subar A.F., Mouw T., et al. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev 15 (2006) 1654-1659
123. Linos E., Raine T., Alonso A., and Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99 (2007) 1544-1550
124. Liu Y., Scheurer M.E., El-Zein R., et al. Association and Interactions between DNA Repair Gene Polymorphisms and Adult Glioma. Cancer Epidemiol Biomarkers Prev 18 (2009) 204-214
125. Liu Y., Zhang H., Zhou K., et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 28 (2007) 1906-1913
126. Liu Y., Zhou K., Zhang H., et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29 (2008) 381-389
127. Longstreth Jr. W.T., Phillips L.E., Drangsholt M., et al. Dental X-rays and the risk of intracranial meningioma: a population-based case-control study. Cancer 100 (2004) 1026-1034
128. Lonn S., Ahlbom A., Hall P., and Feychting M. Long-term mobile phone use and brain tumor risk. Am J Epidemiol 161 (2005) 526-535
129. Lonn S., Klaeboe L., Hall P., et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 108 (2004) 450-455
130. Louis D.N., Ohgaki H., Wiestler O.D., and Cavennee W.C. WHO classification of tumours of the central nervous system (2007), International agency for research on cancer, Lyon
131. Loyant V., Jaffre A., Breton J., et al. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents. Mutagenesis 20 (2005) 365-373
132. Lu Z., Cao Y., Wang Y., et al. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J Neurooncol 85 (2007) 65-73
133. Lubin F., Farbstein H., Chetrit A., et al. The role of nutritional habits during gestation and child life in pediatric brain tumor etiology. Int J Cancer 86 (2000) 139-143
134. Mainio A., Hakko H., Koivukangas J., Niemela A., and Rasanen P. Winter birth in association with a risk of brain tumor among a Finnish patient population. Neuroepidemiology 27 (2006) 57-60
135. Malmer B., Adatto P., Armstrong G., et al. GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev 16 (2007) 1730-1734
136. Malmer B., Gronberg H., Bergenheim A.T., Lenner P., and Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 81 (1999) 366-370
137. Malmer B., Henriksson R., and Gronberg H. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology 21 (2002) 279-286
138. Malmer B., Henriksson R., and Gronberg H. Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 106 (2003) 260-263
139. Malmer B., Iselius L., Holmberg E., et al. Genetic epidemiology of glioma. Br J Cancer 84 (2001) 429-434
140. Maluf F.C., DeAngelis L.M., Raizer J.J., and Abrey L.E. High-grade gliomas in patients with prior systemic malignancies. Cancer 94 (2002) 3219-3224
141. McCarthy B.J., and Kruschko C. Consensus conference on cancer registration of brain and central nervous system tumors. Neuro Oncol 7 (2005) 196-201
142. McCarthy B.J., Propp J.M., Davis F.G., and Burger P.C. Time trends in oligodendroglial and astrocytic tumor incidence. Neuroepidemiology 30 (2008) 34-44
143. McCarthy B.J., Surawicz T., Bruner J.M., Kruchko C., and Davis F. Consensus Conference on Brain Tumor Definition for registration. November 10, 2000. Neuro Oncol 4 (2002) 134-145
144. McKean-Cowdin R., Pogoda J.M., Lijinsky W., et al. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int J Epidemiol 32 (2003) 211-217
145. McKinley B.P., Michalek A.M., Fenstermaker R.A., and Plunkett R.J. The impact of age and sex on the incidence of glial tumors in New York State from 1976 to 1995. J Neurosurg 93 (2000) 932-939
146. McKinney P.A. Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry 75 Suppl 2 (2004) ii12-ii17
147. McNally R.J., Cairns D.P., Eden O.B., et al. An infectious aetiology for childhood brain tumours? Evidence from space-time clustering and seasonality analyses. Br J Cancer 86 (2002) 1070-1077
148. McNeil D.E., Cote T.R., Clegg L., and Rorke L.B. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results. Med Pediatr Oncol 39 (2002) 190-194
149. Miller K.L., Kelsey K.T., Wiencke J.K., et al. The C3435T polymorphism of MDR1 and susceptibility to adult glioma. Neuroepidemiology 25 (2005) 85-90
150. Minder C.E., and Pfluger D.H. Leukemia, brain tumors, and exposure to extremely low frequency electromagnetic fields in Swiss railway employees. Am J Epidemiol 153 (2001) 825-835
151. Minniti G., Traish D., Ashley S., Gonsalves A., and Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90 (2005) 800-804
152. Mittler M.A., Walters B.C., and Stopa E.G. Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 85 (1996) 1091-1094
153. Mogren I., Malmer B., Tavelin B., and Damber L. Reproductive factors have low impact on the risk of different primary brain tumours in offspring. Neuroepidemiology 22 (2003) 249-254
154. Mueller B.A., Nielsen S.S., Preston-Martin S., et al. Household water source and the risk of childhood brain tumours: results of the SEARCH International Brain Tumor Study. Int J Epidemiol 33 (2004) 1209-1216
155. Muscat J.E., Hinsvark M., and Malkin M. Mobile telephones and rates of brain cancer. Neuroepidemiology 27 (2006) 55-56
156. Narod S.A., Stiller C., and Lenoir G.M. An estimate of the heritable fraction of childhood cancer. Br J Cancer 63 (1991) 993-999
157. Navas-Acien A., Pollan M., Gustavsson P., and Plato N. Occupation, exposure to chemicals and risk of gliomas and meningiomas in Sweden. Am J Ind Med 42 (2002) 214-227
158. Neglia J.P., Robison L.L., Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98 (2006) 1528-1537
159. Nomura K. Epidemiology of germ cell tumors in Asia of pineal region tumor. J Neurooncol 54 (2001) 211-217
160. O'Neill B.P., Blondal H., Yang P., et al. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 11 (2002) 921-924
161. Ohgaki H., and Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 109 (2005) 93-108
162. Olson J.E., Janney C.A., Rao R.D., et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95 (2002) 1504-1510
163. Patel A., van Meyel D.J., Mohapatra G., et al. Gliomas in families: chromosomal analysis by comparative genomic hybridization. Cancer Genet Cytogenet 100 (1998) 77-83
164. Paunu N., Pukkala E., Laippala P., et al. Cancer incidence in families with multiple glioma patients. Int J Cancer 97 (2002) 819-822
165. Paunu N., Sallinen S.L., Karhu R., et al. Chromosome imbalances in familial gliomas detected by comparative genomic hybridization. Genes Chromosomes Cancer 29 (2000) 339-346
166. Paunu N., Syrjakoski K., Sankila R., et al. Analysis of p53 tumor suppressor gene in families with multiple glioma patients. J Neurooncol 55 (2001) 159-165
167. Pettorini B.L., Park Y.S., Caldarelli M., et al. Radiation-induced brain tumours after central nervous system irradiation in childhood: a review. Childs Nerv Syst 24 (2008) 793-805
168. Phillips L.E., Frankenfeld C.L., Drangsholt M., et al. Intracranial meningioma and ionizing radiation in medical and occupational settings. Neurology 64 (2005) 350-352
169. Phillips L.E., Longstreth Jr. W.T., Koepsell T., et al. Active and passive cigarette smoking and risk of intracranial meningioma. Neuroepidemiology 24 (2005) 117-122
170. Pobereskin L.H. The completeness of brain tumour registration in Devon and Cornwall. Eur J Epidemiol 17 (2001) 413-416
171. Pobereskin L.H., and Chadduck J.B. Incidence of brain tumours in two English counties: a population based study. J Neurol Neurosurg Psychiatry 69 (2000) 464-471
172. Preston D.L., Ron E., Yonehara S., et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94 (2002) 1555-1563
173. Preston-Martin S., Pogoda J.M., Mueller B.A., et al. Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 5 (1996) 599-605
174. Propp J.M., McCarthy B.J., Davis F.G., and Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 8 (2006) 1-11
175. Provost D., Cantagrel A., Lebailly P., et al. Brain tumours and exposure to pesticides: a case-control study in southwestern France. Occup Environ Med 64 (2007) 509-514
176. Radhakrishnan K., Mokri B., Parisi J.E., et al. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 37 (1995) 67-73
177. Rajaraman P., Schwartz B.S., Rothman N., et al. Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect 113 (2005) 1209-1211
178. Rajaraman P., Stewart P.A., Samet J.M., et al. Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 15 (2006) 2514-2520
179. Rajaraman P., Wang S.S., Rothman N., et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 16 (2007) 1655-1661
180. Relling M.V., Rubnitz J.E., Rivera G.K., et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354 (1999) 34-39
181. Rollison D.E., Helzlsouer K.J., Alberg A.J., et al. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev 12 (2003) 460-463
182. Rollison D.E., Page W.F., Crawford H., et al. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine. Am J Epidemiol 160 (2004) 317-324
183. Ron E., Modan B., Boice Jr. J.D., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319 (1988) 1033-1039
184. Ronckers C.M., Land C.E., Verduijn P.G., et al. Cancer mortality after nasopharyngeal radium irradiation in the Netherlands: a cohort study. J Natl Cancer Inst 93 (2001) 1021-1027
185. Roosli M., Lortscher M., Egger M., et al. Leukaemia, brain tumours and exposure to extremely low frequency magnetic fields: cohort study of Swiss railway employees. Occup Environ Med 64 (2007) 553-559
186. Roser F., Nakamura M., Bellinzona M., et al. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 57 (2004) 1033-1037
187. Ryan P., Lee M.W., North B., and McMichael A.J. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51 (1992) 20-27
188. Sadetzki S., Chetrit A., Freedman L., et al. Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res 163 (2005) 424-432
189. Sadetzki S., Flint-Richter P., Starinsky S., et al. Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 14 (2005) 969-976
190. Saika K., and Hirabayashi Y. Comparison of time trends in brain central nervous system cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV-VIII. Jpn J Clin Oncol 38 (2008) 650-652
191. Salminen E., Pukkala E., and Teppo L. Second cancers in patients with brain tumours--impact of treatment. Eur J Cancer 35 (1999) 102-105
192. Samanic C.M., De Roos A.J., Stewart P.A., et al. Occupational exposure to pesticides and risk of adult brain tumors. Am J Epidemiol 167 (2008) 976-985
193. Samuelsen S.O., Bakketeig L.S., Tretli S., Johannesen T.B., and Magnus P. Head circumference at birth and risk of brain cancer in childhood: a population-based study. Lancet Oncol 7 (2006) 39-42
194. Schellinger K.A., Propp J.M., Villano J.L., and McCarthy B.J. Descriptive epidemiology of primary spinal cord tumors. J Neurooncol 87 (2008) 173-179
195. Scheurer M.E., El-Zein R., Thompson P.A., et al. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev 17 (2008) 1277-1281
196. Scheurer M.E., Etzel C.J., Liu M., et al. Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 16 (2007) 2491-2495
197. Schlehofer B., Blettner M., Preston-Martin S., et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82 (1999) 155-160
198. Schlehofer B., Hettinger I., Ryan P., et al. Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int J Cancer 113 (2005) 116-125
199. Schneider B., Pulhorn H., Rohrig B., and Rainov N.G. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 29 (2005) 440-447
200. Schoemaker M.J., Swerdlow A.J., Hepworth S.J., et al. History of allergies and risk of glioma in adults. Int J Cancer 119 (2006) 2165-2172
201. Schrell U.M., Adams E.F., Fahlbusch R., et al. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73 (1990) 743-749
202. Schulze-Rath R., Hammer G.P., and Blettner M. Are pre- or postnatal diagnostic X-rays a risk factor for childhood cancer? A systematic review. Radiat Environ Biophys 47 (2008) 301-312
203. Schuz J., Bohler E., Berg G., et al. Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). Am J Epidemiol 163 (2006) 512-520
204. Schuz J., Jacobsen R., Olsen J.H., et al. Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst 98 (2006) 1707-1713
205. Schuz J., Kaletsch U., Kaatsch P., Meinert R., and Michaelis J. Risk factors for pediatric tumors of the central nervous system: results from a German population-based case-control study. Med Pediatr Oncol 36 (2001) 274-282
206. Schwartzbaum J., Ahlbom A., Malmer B., et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65 (2005) 6459-6465
207. Schwartzbaum J., Jonsson F., Ahlbom A., et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 106 (2003) 423-428
208. Schwartzbaum J.A., Ahlbom A., Lonn S., et al. An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev 16 (2007) 2448-2454
209. Shah K.V. SV40 and human cancer: a review of recent data. Int J Cancer 120 (2007) 215-223
210. Shaw A.K., Li P., and Infante-Rivard C. Early infection and risk of childhood brain tumors (Canada). Cancer Causes Control 17 (2006) 1267-1274
211. Silvera S.A., Miller A.B., and Rohan T.E. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer 118 (2006) 1848-1851
212. Sirachainan N., Wongruangsri S., Kajanachumpol S., et al. Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children. Cancer Detect Prev 32 (2008) 72-78
213. Sivak-Sears N.R., Schwartzbaum J.A., Miike R., Moghadassi M., and Wrensch M. Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme. Am J Epidemiol 159 (2004) 1131-1139
214. Sorahan T., Nichols L., van Tongeren M., and Harrington J.M. Occupational exposure to magnetic fields relative to mortality from brain tumours: updated and revised findings from a study of United Kingdom electricity generation and transmission workers, 1973-97. Occup Environ Med 58 (2001) 626-630
215. Tachibana I., Smith J.S., Sato K., et al. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet 92 (2000) 136-141
216. Takebayashi T., Varsier N., Kikuchi Y., et al. Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case-control study. Br J Cancer 98 (2008) 652-659
217. Tedeschi-Blok N., Lee M., Sison J.D., Miike R., and Wrensch M. Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study. BMC Cancer 6 (2006) 148
218. Theriault G., Goldberg M., Miller A.B., et al. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am J Epidemiol 139 (1994) 550-572
219. van Tongeren M., Mee T., Whatmough P., et al. Assessing occupational and domestic ELF magnetic field exposure in the UK adult brain tumour study: results of a feasibility study. Radiat Prot Dosimetry 108 (2004) 227-236
220. van Wijngaarden E., and Dosemeci M. Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int J Cancer 119 (2006) 1136-1144
221. Vega A., Sobrido M.J., Ruiz-Ponte C., Barros F., and Carracedo A. Rare HRAS1 alleles are a risk factor for the development of brain tumors. Cancer 92 (2001) 2920-2926
222. Villeneuve P.J., Agnew D.A., Johnson K.C., and Mao Y. Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control study. Int J Epidemiol 31 (2002) 210-217
223. Von Behren J., and Reynolds P. Birth characteristics and brain cancers in young children. Int J Epidemiol 32 (2003) 248-256
224. Wang L.E., Bondy M.L., Shen H., et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64 (2004) 5560-5563
225. Wiemels J.L., Wiencke J.K., Patoka J., et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 64 (2004) 8468-8473
226. Wiemels J.L., Wiencke J.K., Sison J.D., et al. History of allergies among adults with glioma and controls. Int J Cancer 98 (2002) 609-615
227. Wigertz A., Lonn S., Mathiesen T., et al. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164 (2006) 629-636
228. Wigertz A., Lonn S., Schwartzbaum J., et al. Allergic conditions and brain tumor risk. Am J Epidemiol 166 (2007) 941-950
229. Wrensch M., Kelsey K.T., Liu M., et al. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol 7 (2005) 495-507
230. Wrensch M., Lee M., Miike R., et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145 (1997) 581-593
231. Wrensch M., Minn Y., Chew T., Bondy M., and Berger M.S. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4 (2002) 278-299
232. Wrensch M., Weinberg A., Wiencke J., et al. Does prior infection with varicella-zoster virus influence risk of adult glioma?. Am J Epidemiol 145 (1997) 594-597
233. Wrensch M., Weinberg A., Wiencke J., et al. Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 154 (2001) 161-165
234. Wrensch M., Weinberg A., Wiencke J., et al. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am J Epidemiol 161 (2005) 929-938
235. Wrensch M., Yost M., Miike R., Lee G., and Touchstone J. Adult glioma in relation to residential power frequency electromagnetic field exposures in the San Francisco Bay area. Epidemiology 10 (1999) 523-527
236. Wurm G., Parsaei B., Silye R., and Fellner F.A. Distinct supratentorial lesions mimicking cerebral gliomas. Acta Neurochir (Wien) 146 (2004) 19-26 discussion 26
237. Yonehara S., Brenner A.V., Kishikawa M., et al. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995. Cancer 101 (2004) 1644-1654
238. Zhou X.P., Sanson M., Hoang-Xuan K., et al. Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Francaise. Ann Neurol 46 (1999) 913-916